Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression
Lucia Giordanengo, Alessia Proment, V. Bottà, Francesca Picca, Hafsa Munir, Jiahao Tao, Martina Olivero, Riccardo Taulli, Francesca Bersani, Dario Sangiolo, Silvia Novello, Giorgio V. Scagliotti, Alessandra Merlini, Gabriella Doronzo
Abstract
Endothelial-to-mesenchymal transition (EndMT) is a dynamic cellular process characterized by a phenotypic-functional switch of cells from endothelial-to-mesenchymal traits. Many studies have identified EndMT as a key driver of tumor growth and progression. EndMT supports tumor cell proliferation by creating a tumor microenvironment that facilitates cancer cell survival. Notably, EndMT is an important source of cancer-associated fibroblasts, leads to immune dysregulation and immune escape, and supports metastasis and resistance to therapy. Hence, understanding the intricate relationship between EndMT and cancer progression offers exciting new avenues for therapeutic intervention. This review aims to describe the central role of EndMT in tumor progression, highlighting the molecular mechanisms underlying this endothelial alteration and its significant involvement at all stages of tumor progression.